Unlike in the rest of the country, where intestinal ultrasound rarely is used in the clinic, in New York City, gastroenterologists at Mount Sinai Hospital have made IUS findings the “the fifth vital sign” for inflammatory bowel disease patient care, particularly to monitor disease. Now, new research from the institution and other centers is showing that the tool can identify patients with endoscopic recurrence and possibly predict disease outcomes and treatment response.
Trending
- Experts weigh in on liability over AI use in healthcare (Healio)
- Ascension’s Outpatient Surgery Volume Rose Nearly 400% After AMSURG Buy (ASC News)
- CMS Finalizes Reassignment of Gastric Alimetry® Test to Higher Payment Level, Increasing Medicare Hospital Outpatient Payment by Approximately 144% (Globe Newswire )
- MedInTech Secures $25.7 Million for AI Robotics Expansion (DistilINFO)
- AI-assisted colonoscopy and disease-specific imaging show benefits in ulcerative colitis (Hospital Healthcare Europe)
- The race to understand why young people are dying from colon cancer (Scientific American)
- What the Robot Still Can’t Do (NEJM)
- Geneoscopy Resolves Patent and False Advertising Litigation with Exact Sciences Following a Series of Victories at the Patent Trial and Appeal Board (PR Newswire)
